GRAS Oversight and Transparency Act
- Sponsor
- Rep. Lawler, Michael [R-NY-17]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Jan 30, 2026
Bottom line
The GRAS Oversight and Transparency Act creates a new federal board to re-evaluate the safety of older, unreviewed manufacturer-determined GRAS food ingredients, with potential for revocation and penalties for non-compliant manufacturers.
What it actually does
This bill establishes a new board within the Department of Health and Human Services, acting through the Food and Drug Administration, to review the safety of certain food substances designated as 'Generally Recognized As Safe' (GRAS) by manufacturers before the year 2000, especially those not formally notified to the FDA. The board will categorize these substances by review priority, assess their validity, and recommend revocation if a substance is not shown to be safe. Manufacturers are required to identify these GRAS designations or face penalties.
Proponents argue
Proponents argue that this bill addresses a critical loophole in food safety regulations, ensuring that substances widely used in food for decades, but never formally reviewed by the FDA, are subject to modern scientific scrutiny. They contend it will enhance consumer confidence in food safety by closing the 'self-GRAS' notification gap for older ingredients, particularly those designated before the FDA's formal notification program was established, thereby protecting public health from potentially unsafe additives.
Opponents contend
Opponents might argue that this bill imposes an undue burden on food manufacturers, particularly smaller businesses, by requiring them to re-submit extensive scientific evidence for substances that have been in use for decades without reported issues. They may contend that the existing GRAS notification process is sufficient and that creating a new board with a 10-year review timeline is an inefficient use of resources that could stifle innovation or lead to unnecessary removal of safe ingredients from the market, potentially increasing food costs for consumers.
The bill is relatively short and straightforward, making it accessible for a quick read and understanding of its core mechanisms.
Section 2(a)
Establishment of GRAS Review Board
This provision directs the Secretary of Health and Human Services, through the Commissioner of Food and Drugs, to create a new board. The primary purpose of this board is to review the validity of 'covered GRAS designations,' which are specific types of manufacturer-determined Generally Recognized As Safe (GRAS) statuses for food substances.
Supporters argue
Supporters argue that establishing a dedicated board ensures a focused and systematic review of potentially overlooked GRAS substances, providing necessary oversight that current mechanisms may not fully address.
Critics contend
Critics might contend that creating a new board adds another layer of bureaucracy, potentially duplicating efforts or slowing down existing regulatory processes within the FDA.
Tradeoffs
The tradeoff involves balancing the need for enhanced oversight of food safety with the potential for increased administrative complexity and resource allocation within federal agencies.
Section 2(b)
Board Membership and Structure
This section outlines the composition of the GRAS Review Board, including voting members from HHS, USDA, FDA's Human Foods Program, and various offices within FDA, USDA, and EPA. It also includes non-voting members: an academic expert in food toxicology and a representative from the food manufacturing industry. Members serve five-year terms without compensation, and the Secretary designates a chairperson.
Section 2(c)
Board Duties and Review Process
The Board is tasked with reviewing all identified 'covered GRAS designations.' This review involves three stages: identifying the scope of designations (with manufacturer participation), categorizing them into Tier 1, 2, or 3 based on priority (Tier 1 being highest), and then conducting a validity review for each. If a substance is determined not to be safe, the Board must notify the Secretary and Congress, recommending revocation.
Section 2(d)
Manufacturer Participation and Penalties
This section mandates that food manufacturers provide notice to the Board within 90 days of enactment, identifying all 'covered GRAS designations' attributable to them and any other requested information. Failure to comply can result in civil penalties (as per 21 U.S.C. 335b(a)) or the Secretary treating the substance as an unapproved food additive, deeming it unsafe under 21 U.S.C. 348.
Section 2(e)
Revocation of Certain GRAS Designations
Upon receiving a recommendation from the Board that a substance is not safe, the Secretary may revoke its 'covered GRAS designation.' If the Secretary decides to revoke, the manufacturer is notified, provided 180 days to submit scientific evidence of safety, and the decision is reviewed based on this new evidence. The Secretary must also establish procedures for manufacturers to comply with revocations, including timelines for ceasing distribution and recalling substances.
Section 2(f)
Public Reporting and Timelines
The Board is required to submit reports to the Secretary and Congress, and make them publicly available on the FDA website, detailing the review process and any recommendations, including notifications for revocation. These reports are staggered: Tier 1 designations within 2 years of enactment, Tier 2 within 4 years, and Tier 3 within 10 years.
Section 2(g)(1)
Definition of 'Covered GRAS Designation'
This section defines 'covered GRAS designation' as a manufacturer's determination, made before the year 2000, that a substance used in food is Generally Recognized As Safe (GRAS). Crucially, it includes designations where the manufacturer did not file a petition or otherwise notify the Secretary of such designation, targeting the 'self-GRAS' loophole for older ingredients.
Section 2(h)
Termination of Board
This provision stipulates that the GRAS Review Board will terminate, and the Act will cease to be effective, 10 years after the date of its enactment. This sets a sunset clause for the entire regulatory framework established by the bill.
If a food manufacturer fails to comply with the requirement to identify its covered GRAS designations, the Secretary may treat the substance as an unapproved food additive under section 409 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 348) and deem it unsafe under that section.
Section 2(d)(2)(B)
Why it matters:This is standard legislative practice to integrate new enforcement mechanisms with existing legal frameworks, avoiding redundant text. However, it requires familiarity with the referenced statute to fully grasp the severity of the consequence.
Case for: Proponents would argue that this strong enforcement mechanism is necessary to compel manufacturers to disclose information about their GRAS substances, ensuring the Board has a complete inventory to review. Without such a powerful deterrent, manufacturers might choose to ignore the reporting requirement.
Case against: Opponents might contend that deeming a substance 'unsafe' without a specific safety review, merely for a reporting failure, is an overly punitive measure that could lead to the removal of genuinely safe ingredients from the market, causing economic disruption without a direct public health benefit.
Estimated impact: This provision significantly raises the stakes for manufacturer compliance, potentially leading to widespread product reformulation or removal if many manufacturers fail to report.
The definition of 'covered GRAS designation' explicitly includes designations made by a manufacturer 'in which such manufacturer has not filed a petition under section 409 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 348) or otherwise notified the Secretary of such designation.'
Section 2(g)(1)
Why it matters:This is a technical but essential clarification that defines the precise scope of the bill. It's placed in definitions because it's foundational to understanding which substances are subject to review.
Case for: Proponents argue that this language is vital because it specifically targets the category of GRAS substances that have historically lacked any form of FDA review or notification, addressing a long-standing concern about transparency and oversight in food safety.
Case against: Opponents might argue that targeting these un-notified substances, many of which have been in use for decades without incident, is an overreach, especially if manufacturers genuinely believed they met GRAS criteria based on scientific consensus at the time.
Estimated impact: This definition significantly expands the universe of GRAS substances subject to federal review, potentially encompassing a large number of ingredients currently in the food supply that have never been formally assessed by the FDA.